Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001021561-13-000117)

Filing Details

Accession Number:
0001021561-13-000117
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-04 18:15:53
Reporting Period:
2013-12-02
Filing Date:
2013-12-04
Accepted Time:
2013-12-04 18:15:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1021561 Nu Skin Enterprises Inc NUS Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 870565309
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289557 R Daniel Chard C/O Nu Skin Enterprises, Inc.
75 West Center Street
Provo UT 84601		 President No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2013-08-14 1,000 $0.00 37,895 No 5 G Direct
Class A Common Stock Acquisiton 2013-12-02 12,500 $17.75 50,395 No 4 M Direct
Class A Common Stock Acquisiton 2013-12-02 60,000 $16.50 110,395 No 4 M Direct
Class A Common Stock Disposition 2013-12-02 72,500 $125.39 37,895 No 4 S Direct
Class A Common Stock Disposition 2013-12-03 6,000 $0.00 31,895 No 5 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 5 G Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (right to buy) Disposition 2013-12-02 12,500 $0.00 12,500 $17.75
Class A Common Stock Employee Stock Option (right to buy) Disposition 2013-12-02 60,000 $0.00 60,000 $16.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-02-26 No 4 M Direct
0 2014-12-20 No 4 M Direct
Footnotes
  1. Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
  2. Currently exercisable in full.